Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy
@article{Shami2003RecombinantAF, title={Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy}, author={V. Shami and S. Caldwell and E. E. Hespenheide and K. Arseneau and S. Bickston and B. Macik}, journal={Liver Transplantation}, year={2003}, volume={9} }
Severe coagulopathy in fulminant hepatic failure (FHF) is difficult to correct by conventional means. Recombinant activated factor VII (rFVIIa) is an antihemophilic factor that has shown promise in treating coagulopathy in liver disease. Our aim is to review our experience with rFVIIa in treating the coagulopathy of FHF and compare these results with those of conventional therapy. Fifteen patients with FHF who met King's College criteria for orthotopic liver transplantation were studied. All… CONTINUE READING
Topics from this paper
213 Citations
Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
- Medicine
- Transplantation proceedings
- 2005
- 19
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: A report of four cases
- Medicine
- Canadian journal of anaesthesia = Journal canadien d'anesthesie
- 2005
- 94
- PDF
Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
- Medicine
- Clinical and laboratory haematology
- 2006
- 19
The use of recombinant factor VIIa in liver diseases
- Medicine
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- 2008
- 22
Clinical Usefulness of Recombinant Activated Factor VII in Patients with Liver Failure Undergoing Invasive Procedures
- Medicine
- The Annals of pharmacotherapy
- 2011
- 24
Recombinant factor VIIa: life-saving therapy in a patient with massive bleeding and hepatic failure
- Medicine
- 2015
The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of an Intracranial Pressure Monitor
- Medicine
- The Annals of pharmacotherapy
- 2011
- 7
Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand
- Medicine
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- 2010
- 9
Activated recombinant factor VII in orthotopic liver transplantation.
- Medicine
- Transplantation proceedings
- 2007
- 33
References
SHOWING 1-10 OF 27 REFERENCES
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy.
- Medicine
- Gastroenterology
- 2002
- 165
The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa.
- Medicine
- Seminars in thrombosis and hemostasis
- 2000
- 34
REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION: A Pilot Study
- Medicine
- Transplantation
- 2001
- 251
- PDF
Controlled trial of antithrombin III supplementation in fulminant hepatic failure.
- Medicine
- Journal of hepatology
- 1993
- 30
Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study.
- Medicine
- Gastroenterology
- 1997
- 262
Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation
- Medicine
- Hepatology
- 2002
- 73
Recombinant activated factor VII as a universal haemostatic agent.
- Medicine
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- 1998
- 122
Clinical experience with recombinant factor VIIa.
- Medicine
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- 1998
- 211
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a Phase I study
- Medicine
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- 1993
- 65